Recently, three scientists at ARUP published a study that shows how symptoms of CM-AVM can be distinguished from a similar disorder, hereditary hemorrhagic telangiectasia (HHT).
The plague provides a subject for Mark Fisher’s current National Institutes of Health (NIH) grant-funded project.
ARUP’s Tech Fair showcases the inventions and innovations of individuals in Automation Engineering, Clinical Systems, Information Technology, and other in-house “builders.”